Reduction of a chronic bilateral temporomandibular joint dislocation with intermaxillary fixation and botulinum toxin A

British Journal of Oral and Maxillofacial Surgery

Volumn 42, Issue 3, 2004, Pages 272-273

  Aquilina, Peter ^a,b   Vickers, Richard ^a   McKellar, Geoffrey ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

Botulinum; Hypercholesterolaemia; IMF

Indexed keywords

BOTULINUM TOXIN A; NITRAZEPAM; SOTALOL;

AGED; ARTICLE; BONE SCREW; CASE REPORT; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC PROCEDURE; FACE PAIN; HOSPITAL DEPARTMENT; HUMAN; JAW MOVEMENT; JOINT DISLOCATION; JOINT SURGERY; MALE; MAXILLA; MOTOR DYSFUNCTION; PATIENT REFERRAL; SURGICAL TECHNIQUE; TEMPOROMANDIBULAR JOINT DISORDER; TIME; TREATMENT OUTCOME;

EID: 2442529552     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2004.01.010     Document Type: Article

References (5)

1. Collins DR, Hogan J, O'Neill D. Temporomandibular dislocation in association with stroke. Ir Med J 1999;92:6.
2. Daelen B, Thorwith V, Koch A. Treatment of recurrent dislocation of the temporomandibular joint with type A botulinum toxin. Int J Oral Maxillofac Surg 1997;26:358-460.
3. Moore AP, Wood GD. Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A. Br Dent J 1997;183:415-7.
4. O'Day J. Use of botulinum toxin in neuro-opthalmology. Curr Opin Opthalmol 2001;12:419-22.
5. Allergan Australia Product Information, 77 Ridge Street Gordon, NSW 2072. Therapeutic goods administration approval, 2002 Mar 19.